Document is current
Any future updates will be listed below
-
Authors
Carmen, Joshua M.
Shrivastava, Shikha https://orcid.org/0000-0001-6276-0791
Lu, Zhongyan
Anderson, Alexander https://orcid.org/0000-0002-0000-7734
Morrison, Elaine B.
Sankhala, Rajeshwer S.
Chen, Wei-Hung https://orcid.org/0000-0003-3724-9195
Chang, William C. https://orcid.org/0000-0003-4967-6426
Bolton, Jessica S.
Matyas, Gary R. https://orcid.org/0000-0002-2074-2373
Michael, Nelson L. https://orcid.org/0000-0001-5882-5548
Joyce, M. Gordon https://orcid.org/0000-0002-6808-7232
Modjarrad, Kayvon
Currier, Jeffrey R. https://orcid.org/0000-0002-5696-0268
Bergmann-Leitner, Elke https://orcid.org/0000-0002-8571-8956
Malloy, Allison M. W. https://orcid.org/0000-0003-2962-0302
Rao, Mangala https://orcid.org/0000-0001-9553-4969
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-18-2-0040)
United States Department of Defense | Uniformed Services University of the Health Sciences (PED-86-10342, PED-86-10342)
- License Information
-
More Information
Article History
Received: 12 May 2021
Accepted: 9 November 2021
First Online: 13 December 2021
Competing interests
: M.G.J. and K.M. are named as inventors on International Patent Application No. WO/2021/21405 entitled “Vaccines against SARS-CoV-2 and other coronaviruses.” M.G.J. is named as an inventor on International Patent Application No. WO/2018/081318 and US Patent 10,960,070 entitled “Prefusion Coronavirus Spike Proteins and Their Use” The remaining authors declare no competing interests.
